...
首页> 外文期刊>Animal Cells and Systems >Sumoylation of the histone demethylase KDM4A is required for binding to tumor suppressor p53 in HCT116 colon cancer cell lines
【24h】

Sumoylation of the histone demethylase KDM4A is required for binding to tumor suppressor p53 in HCT116 colon cancer cell lines

机译:组蛋白脱甲基酶KDM4A的苏氨化需要与HCT116结肠癌细胞系中的肿瘤抑制因子p53结合

获取原文

摘要

The histone demethylase lysine-specific demethylase 4A (KDM4A/Jmjd2A) has diverse functions, including involvement in gene regulation and cell cycle, and plays an oncogenic role in cancer cells. The modulation of KDM4A through post-translational modifications remains unclear. Here, we show that small ubiquitin-like modifier (SUMO) 1-mediated modification of KDM4A was required for interaction with tumor suppressor p53. Our data revealed that KDM4A is mainly sumoylated at lysine residue 471. However, the SUMO modification resulted in little change in subcellular localization, demethylase activity, or protein stability of KMD4A. Intriguingly, co-immunoprecipitation data revealed that sumoylation-defective mutants of KDM4A had a lower binding ability with p53 compared to that of wild-type KDM4A, suggesting a positive role for sumoylation in the interaction between KDM4A and p53. Together, these data suggest that KDM4A is post-translationally modified by SUMO, and this sumoylation may be a novel regulatory switch for controlling the interplay between KDM4A and p53.
机译:组蛋白脱甲基酶赖氨酸特异性脱甲基酶4A(KDM4A / Jmjd2A)具有多种功能,包括参与基因调控和细胞周期,并在癌细胞中起致癌作用。通过翻译后修饰对KDM4A的调节仍不清楚。在这里,我们显示小泛素样修饰剂(SUMO)1介导的KDM4A修饰是与肿瘤抑制因子p53相互作用所必需的。我们的数据显示KDM4A主要在赖氨酸残基471处被磺酰化。但是,SUMO修饰导致KMD4A的亚细胞定位,脱甲基酶活性或蛋白质稳定性几乎没有变化。有趣的是,免疫共沉淀数据表明,与野生型KDM4A相比,KDM4A的sumoylation缺陷型突变体与p53的结合能力较低,这表明sumoylation在KDM4A和p53之间的相互作用中具有积极作用。总之,这些数据表明,SUMO可以对KDM4A进行翻译后修饰,而这种磺酰化反应可能是控制KDM4A与p53之间相互作用的新型调节开关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号